Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 189153, 26 pages
http://dx.doi.org/10.1155/2015/189153
Review Article

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines

1Department of Health Sciences, University of Genoa, Via Pastore 1, 16132 Genoa, Italy
2Department of Health Sciences, University of Florence, Viale G.B. Morgagni 48, 50134 Florence, Italy

Received 21 January 2015; Accepted 9 June 2015

Academic Editor: Nejat K. Egilmez

Copyright © 2015 R. Gasparini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Murakami, T. Ohtake, R. A. Dorschner, B. Schittek, C. Garbe, and R. L. Gallo, “Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin,” Journal of Investigative Dermatology, vol. 119, no. 5, pp. 1090–1095, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. D. R. Drake, K. A. Brogden, D. V. Dawson, and P. W. Wertz, “Thematic review series: skin lipids. Antimicrobial lipids at the skin surface,” Journal of Lipid Research, vol. 49, no. 1, pp. 4–11, 2008. View at Google Scholar
  3. R. Medzhitov and C. Janeway Jr., “Innate immunity,” The New England Journal of Medicine, vol. 343, no. 5, pp. 338–344, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Galdiero, A. Falanga, M. Cantisani et al., “Microbe-Host interactions: structure and role of Gram-negative bacterial Porins,” Current Protein and Peptide Science, vol. 13, no. 8, pp. 843–854, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Di Donato, G. F. Draetta, G. Illiano, M. A. Tufano, L. Sommese, and F. Galdiero, “Do porins inhibit the macrophage phagocyting activity by stimulating the adenylate cyclase?” Journal of Cyclic Nucleotide and Protein Phosphorylation Research, vol. 11, no. 2, pp. 87–97, 1986. View at Google Scholar · View at Scopus
  6. F. Galdiero, M. A. Tufano, L. Sommese, A. Folgore, and F. Tedesco, “Activation of complement system by porins extracted from Salmonella typhimurium,” Infection and Immunity, vol. 46, no. 2, pp. 559–563, 1984. View at Google Scholar · View at Scopus
  7. P. Massari, S. Ram, H. Macleod, and L. M. Wetzler, “The role of porins in neisserial pathogenesis and immunity,” Trends in Microbiology, vol. 11, no. 2, pp. 87–93, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Takeda and S. Akira, “Toll-like receptors in innate immunity,” International Immunology, vol. 17, no. 1, pp. 1–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Hayashi, K. D. Smith, A. Ozinsky et al., “The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5,” Nature, vol. 410, no. 6832, pp. 1099–1103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. D. M. Underhill, A. Aderem, F. Hayashi et al., “The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5,” Nature, vol. 410, no. 6832, pp. 1099–1103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Faber, C. U. Meyer, C. Gemmer et al., “Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy,” The Pediatric Infectious Disease Journal, vol. 25, no. 1, pp. 80–81, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. S. Sanders, G. T. J. van Well, S. Ouburg, P. S. J. Lundberg, A. M. Van Furth, and S. A. Morré, “Single nucleotide polymorphisms in TLR9 are highly associated with susceptibility to bacterial meningitis in children,” Clinical Infectious Diseases, vol. 52, no. 4, pp. 475–480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. T.-D. Kanneganti, M. Lamkanfi, and G. Núñez, “Intracellular NOD-like receptors in host defense and disease,” Immunity, vol. 27, no. 4, pp. 549–559, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Denes, G. Lopez-Castejon, and D. Brough, “Caspase-1: is IL-1 just the tip of the ICEberg?” Cell Death and Disease, vol. 3, no. 7, article e338, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. W. Segal, “How neutrophils kill microbes,” Annual Review of Immunology, vol. 23, pp. 197–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. Sun, S. Ugolini, and E. Vivier, “Immunological memory within the innate immune system,” The EMBO Journal, vol. 33, no. 12, pp. 1295–1303, 33. View at Publisher · View at Google Scholar
  18. A. Kolb-Mäurer, A. Unkmeir, U. Kämmerer et al., “Interaction of Neisseria meningitidis with human dendritic cells,” Infection and Immunity, vol. 69, no. 11, pp. 6912–6922, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. S. M. Zughaier, “Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2,” Journal of Leukocyte Biology, vol. 89, no. 3, pp. 469–480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. C. L. Sokol, G. M. Barton, A. G. Farr, and R. Medzhitov, “A mechanism for the initiation of allergen-induced T helper type 2 responses,” Nature Immunology, vol. 9, no. 3, pp. 310–318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Merad, P. Sathe, J. Helft, J. Miller, and A. Mortha, “The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting,” Annual Review of Immunology, vol. 31, pp. 563–604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. C. A. Janeway, P. Travers, M. Walport et al., Immunobiology, Garland Science, New York, NY, USA, 2001.
  23. M. Pizza and R. Rappuoli, “Neisseria meningitidis: pathogenesis and immunity,” Current Opinion in Microbiology, vol. 23, pp. 68–72, 2015. View at Publisher · View at Google Scholar
  24. E. Del Tordello and D. Serruto, “Functional genomics studies of the human pathogen Neisseria meningitidis,” Briefings in Functional Genomics, vol. 12, no. 4, pp. 328–340, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Schoen, H. Tettelin, J. Parkhill, and M. Frosch, “Genome flexibility in Neisseria meningitidis,” Vaccine, vol. 27, supplement 2, pp. B103–B111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. P. M. Power and E. R. Moxon, “Phase variation and adaptive strategies of N. meningitidis: insights into the biology of a commensal and pathogen,” in Handbook of Meningococcal Disease: Infection Biology, Vaccination, Clinical Management, M. Frosch and M. C. J. Maiden, Eds., Wiley-Blackwell, 2006. View at Publisher · View at Google Scholar
  27. E. Rotman and H. S. Seifert, “The genetics of Neisseria species,” Annual Review of Genetics, vol. 48, no. 1, pp. 405–431, 2014. View at Publisher · View at Google Scholar
  28. P. R. Marri, M. Paniscus, N. J. Weyand et al., “Genome sequencing reveals widespread virulence gene exchange among human Neisseria species,” PLoS ONE, vol. 5, no. 7, Article ID e11835, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. A. S. Snyder, S. A. Jarvis, and N. J. Saunders, “Complete and variant forms of the ‘gonococcal genetic island’ in Neisseria meningitidis,” Microbiology, vol. 151, no. 12, pp. 4005–4013, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Joseph, R. F. Schwarz, B. Linke et al., “Virulence evolution of the human pathogen Neisseria meningitidis by recombination in the core and accessory genome,” PLoS ONE, vol. 6, no. 4, Article ID e18441, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. L. A. Cahoon and H. S. Seifert, “Focusing homologous recombination: pilin antigenic variation in the pathogenic Neisseria,” Molecular Microbiology, vol. 81, no. 5, pp. 1136–1143, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Kawai, I. Uchiyama, and I. Kobayashi, “Genome comparison In Silico in Neisseria suggests integration of filamentous bacteriophages by their own transposase,” DNA Research, vol. 12, no. 6, pp. 389–401, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. W. J. van Passel, A. van der Ende, and A. Bart, “Plasmid diversity in neisseriae,” Infection and Immunity, vol. 74, no. 8, pp. 4892–4899, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. N. Srikhanta, K. L. Fox, and M. P. Jennings, “The phasevarion: phase variation of type III DNA methyltransferases controls coordinated switching in multiple genes,” Nature Reviews Microbiology, vol. 8, no. 3, pp. 196–206, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. M. V. R. Weber, H. Claus, M. C. J. Maiden, M. Frosch, and U. Vogel, “Genetic mechanisms for loss of encapsulation in polysialyltransferase-gene-positive meningococci isolated from healthy carriers,” International Journal of Medical Microbiology, vol. 296, no. 7, pp. 475–484, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. A. van der Ende, C. T. P. Hopman, and J. Dankert, “Multiple mechanisms of phase variation of PorA in Neisseria meningitidis,” Infection and Immunity, vol. 68, no. 12, pp. 6685–6690, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Martin, K. Makepeace, S. A. Hill, D. W. Hood, and E. R. Moxon, “Microsatellite in instability regulates transcription factor binding and gene expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 10, pp. 3800–3804, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Tobes and E. Pareja, “Bacterial repetitive extragenic palindromic sequences are DNA targets for Insertion Sequence elements,” BMC Genomics, vol. 7, article 62, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Fagnocchi, E. Pigozzi, V. Scarlato, and I. Delany, “In the NadR regulon, adhesins and diverse meningococcal functions are regulated in response to signals in human saliva,” Journal of Bacteriology, vol. 194, no. 2, pp. 460–474, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. L. A. S. Snyder, S. A. Butcher, and N. J. Saunders, “Comparative whole-genome analyses reveal over 100 putative phase-variable genes in the pathogenic Neisseria spp.,” Microbiology, vol. 147, no. 8, pp. 2321–2332, 2001. View at Google Scholar · View at Scopus
  41. A. Rytkönen, B. Albiger, P. Hansson-Palo et al., “Neisseria meningitidis undergoes PilC phase variation and PilE sequence variation during invasive disease,” Journal of Infectious Diseases, vol. 189, no. 3, pp. 402–409, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Martin, L. Sun, D. W. Hood, and E. R. Moxon, “Involvement of genes of genome maintenance in the regulation of phase variation frequencies in Neisseria meningitidis,” Microbiology, vol. 150, no. 9, pp. 3001–3012, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. A. R. Richardson and I. Stojiljkovic, “Mismatch repair and the regulation of phase variation in Neisseria meningitidis,” Molecular Microbiology, vol. 40, no. 3, pp. 645–655, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. L. A. S. Snyder, N. J. Saunders, and W. M. Shafer, “A putatively phase variable gene (dca) required for natural competence in Neisseria gonorrhoeae but not Neisseria meningitidis is located within the division cell wall (dcw) gene cluster,” Journal of Bacteriology, vol. 183, no. 4, pp. 1233–1241, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. P. van Ulsen, B. Adler, P. Fassler et al., “A novel phase-variable autotransporter serine protease, AusI, of Neisseria meningitidis,” Microbes and Infection, vol. 8, no. 8, pp. 2088–2097, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. N. J. Oldfield, S. Matar, F. A. Bidmos et al., “Prevalence and phase variable expression status of two autotransporters, NalP and MspA, in carriage and disease isolates of Neisseria meningitides,” PLoS ONE, vol. 8, no. 7, Article ID e69746, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. M. J. Warren and M. P. Jennings, “Identification and characterization of pptA: a gene involved in the phase-variable expression of phosphorylcholine on pili of Neisseria meningitidis,” Infection and Immunity, vol. 71, no. 12, pp. 6892–6898, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Davidsen, M. Bjørås, E. C. Seeberg, and T. Tønjum, “Antimutator role of DNA glycosylase MutY in pathogenic Neisseria species,” Journal of Bacteriology, vol. 187, no. 8, pp. 2801–2809, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. N. J. Saunders, A. C. Jeffries, J. F. Peden et al., “Repeat-associated phase variable genes in the complete genome sequence of Neisseria meningitidis strain MC58,” Molecular Microbiology, vol. 37, no. 1, pp. 207–215, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. M. M. E. Metruccio, E. Pigozzi, D. Roncarati et al., “A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements,” PLoS Pathogens, vol. 5, no. 12, Article ID e1000710, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. H. L. Alexander, A. W. Rasmussen, and I. Stojiljkovic, “Identification of Neisseria meningitidis genetic loci involved in the modulation of phase variation frequencies,” Infection and Immunity, vol. 72, no. 11, pp. 6743–6747, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Siddique, N. Buisine, and R. Chalmers, “The transposon-like correia elements encode numerous strong promoters and provide a potential new mechanism for phase variation in the meningococcus,” PLoS Genetics, vol. 7, no. 1, Article ID e1001277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Mazzone, E. De Gregorio, A. Lavitola, C. Pagliarulo, P. Alifano, and P. P. Di Nocera, “Whole-genome organization and functional properties of miniature DNA insertion sequences conserved in pathogenic Neisseriae,” Gene, vol. 278, no. 1-2, pp. 211–222, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. E. de Gregorio, C. Abrescia, M. S. Carlomagno, and P. P. di Nocera, “Asymmetrical distribution of Neisseria miniature insertion sequence DNA repeats among pathogenic and nonpathogenic Neisseria strains,” Infection and Immunity, vol. 71, no. 7, pp. 4217–4221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Hilse, S. Hammerschmidt, W. Bautsch, and M. Frosch, “Site-specific insertion of IS1301 and distribution in Neisseria meningitidis strains,” Journal of Bacteriology, vol. 178, no. 9, pp. 2527–2532, 1996. View at Google Scholar · View at Scopus
  56. E. Kugelberg, B. Gollan, C. Farrance et al., “The influence of IS 1301 in the capsule biosynthesis locus on meningococcal carriage and disease,” PLoS ONE, vol. 5, no. 2, Article ID e9413, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Kiss, Z. Nagy, G. Tóth et al., “Transposition and target specificity of the typical IS30 family element IS1655 from Neisseria meningitidis,” Molecular Microbiology, vol. 63, no. 6, pp. 1731–1747, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Tettelin, N. J. Saunders, J. Heidelberg et al., “Complete genome sequence of Neisseria meningitidis serogroup B strain MC58,” Science, vol. 287, no. 5459, pp. 1809–1815, 2000. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Alamro, F. A. Bidmos, H. Chan et al., “Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage,” Infection and Immunity, vol. 82, no. 6, pp. 2472–2484, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. M. P. Jennings, Y. N. Srikhanta, E. R. Moxon et al., “The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis,” Microbiology, vol. 145, no. 11, pp. 3013–3021, 1999. View at Google Scholar · View at Scopus
  61. P. M. Power, L. F. Roddam, M. Dieckelmann et al., “Genetic characterization of pilin glycosylation in Neisseria meningitidis,” Microbiology, vol. 146, no. 4, pp. 967–979, 2000. View at Google Scholar
  62. P. M. Power, L. F. Roddam, K. Rutter, S. Z. Fitzpatrick, Y. N. Srikhanta, and M. P. Jennings, “Genetic characterization of pilin glycosylation and phase variation in Neisseria meningitidis,” Molecular Microbiology, vol. 49, no. 3, pp. 833–847, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. M. M. Estabrook, N. C. Christopher, J. M. Griffiss, C. J. Baker, and R. E. Mandrell, “Sialylation and human neutrophil killing of group C Neisseria meningitidis,” The Journal of Infectious Diseases, vol. 166, no. 5, pp. 1079–1088, 1992. View at Publisher · View at Google Scholar · View at Scopus
  64. Q. Zhang, Y. Li, and C. M. Tang, “The role of the exopolyphosphatase PPX in avoidance by Neisseria meningitidis of complement-mediated killing,” The Journal of Biological Chemistry, vol. 285, no. 44, pp. 34259–34268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Claus, R. Borrow, M. Achtman et al., “Genetics of capsule O-acetylation in serogroup C, W-135 and Y meningococci,” Molecular Microbiology, vol. 51, no. 1, pp. 227–239, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. P. C. Fusco, E. K. Farley, C.-H. Huang, S. Moore, and F. Michon, “Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation,” Clinical and Vaccine Immunology, vol. 14, no. 5, pp. 577–584, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. A. Batista-Duharte, B. Téllez, M. Tamayo et al., “In Silico identification of molecular mimicry between T-cell epitopes of Neisseria meningitidis B and the human proteome,” Revista Peruana de Medicina Experimental y Salud Publica, vol. 30, no. 3, pp. 441–445, 2013. View at Google Scholar · View at Scopus
  68. J. Finne, U. Finne, H. Deagostini-Bazin, and C. Goridis, “Occurrence of α2-8 linked polysialosyl units in a neural cell adhesion molecule,” Biochemical and Biophysical Research Communications, vol. 112, no. 2, pp. 482–487, 1983. View at Publisher · View at Google Scholar · View at Scopus
  69. G. R. Moe and D. M. Granoff, “Molecular mimetics of Neisseria meningitidis serogroup B polysaccharide,” International Reviews of Immunology, vol. 20, no. 2, pp. 201–220, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. R. E. Mandrell and M. A. Apicella, “Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS,” Immunobiology, vol. 187, no. 3–5, pp. 382–402, 1993. View at Publisher · View at Google Scholar · View at Scopus
  71. A. P. Moran, M. M. Prendergast, and B. J. Appelmelk, “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease,” FEMS Immunology and Medical Microbiology, vol. 16, no. 2, pp. 105–115, 1996. View at Publisher · View at Google Scholar · View at Scopus
  72. H. A. Harvey, W. E. Swords, and M. A. Apicella, “The mimicry of human glycolipids and glycosphingolipids by the lipooligosaccharides of pathogenic Neisseria and Haemophilus,” Journal of Autoimmunity, vol. 16, no. 3, pp. 257–262, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. C. M. Tsai, “Molecular mimicry of host structures by lipooligosaccharides of Neisseria meningitidis: characterization of sialylated and nonsialylated lacto-N-neotetraose (Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc) structures in lipooligosaccharides using monoclonal antibodies and specific lectins,” Advances in Experimental Medicine and Biology, vol. 491, pp. 525–542, 2001. View at Google Scholar · View at Scopus
  74. H.-C. Wang, T.-P. Ko, M.-L. Wu, S.-C. Ku, H.-J. Wu, and A. H.-J. Wang, “Neisseria conserved protein DMP19 is a DNA mimic protein that prevents DNA binding to a hypothetical nitrogen-response transcription factor,” Nucleic Acids Research, vol. 40, no. 12, pp. 5718–5730, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Coureuil, G. Mikaty, F. Miller et al., “Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium,” Science, vol. 325, no. 5936, pp. 83–87, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. F. Miller, G. Phan, T. Brissac et al., “The hypervariable region of meningococcal major pilin PilE controls the host cell response via antigenic variation,” mBio, vol. 5, no. 1, Article ID e01024-13, 2013. View at Publisher · View at Google Scholar
  77. M. P. Bos, B. Tefsen, P. Voet, V. Weynants, J. P. M. Van Putten, and J. Tommassen, “Function of neisserial outer membrane phospholipase A in autolysis and assessment of its vaccine potential,” Infection and Immunity, vol. 73, no. 4, pp. 2222–2231, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. I. W. Devoe and J. E. Gilchrist, “Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis,” Journal of Experimental Medicine, vol. 138, no. 5, pp. 1156–1167, 1973. View at Publisher · View at Google Scholar · View at Scopus
  79. J. S. Swartley, A. A. Marfin, S. Edupuganti et al., “Capsule switching of Neisseria meningitidis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 1, pp. 271–276, 1997. View at Publisher · View at Google Scholar · View at Scopus
  80. T. M. P. P. Castiñeiras, D. E. Barroso, J. W. Marsh et al., “Capsular switching in invasive Neisseria meningitidis, Brazil,” Emerging Infectious Diseases, vol. 18, no. 8, pp. 1336–1338, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. P. Stefanelli, C. Fazio, A. Neri, T. Sofia, and P. Mastrantonio, “First report of capsule replacement among electrophoretic type 37 Neisseria meningitidis strains in Italy,” Journal of Clinical Microbiology, vol. 41, no. 12, pp. 5783–5786, 2003. View at Publisher · View at Google Scholar · View at Scopus
  82. R. S. W. Tsang, D. K. S. Law, S. D. Tyler, G. S. Stephens, M. Bigham, and W. D. Zollinger, “Potential capsule switching from serogroup Y to B: the characterization of three such Neisseria meningitidis isolates causing invasive meningococcal disease in Canada,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 16, no. 3, pp. 171–174, 2005. View at Google Scholar · View at Scopus
  83. L. M. Hollanda, G. C. G. Cury, R. F. C. Pereira et al., “Effect of mesoporous silica under Neisseria meningitidis transformation process: environmental effects under meningococci transformation,” Journal of Nanobiotechnology, vol. 9, article 28, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. I. B. Mattos, D. A. Alves, L. M. Hollanda, H. J. Ceragiogli, V. Baranauskas, and M. Lancellotti, “Effects of multi-walled carbon nanotubes (MWCNT) under Neisseria meningitidis transformation process,” Journal of Nanobiotechnology, vol. 9, article 53, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. U. Vogel, M.-K. Taha, J. A. Vazquez et al., “Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment,” The Lancet Infectious Diseases, vol. 13, no. 5, pp. 416–425, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. A. J. Beddek, M.-S. Li, J. S. Kroll, T. W. Jordan, and D. R. Martin, “Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains,” Infection and Immunity, vol. 77, no. 7, pp. 2989–2994, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. L. H. Harrison, K. A. Shutt, S. E. Schmink et al., “Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era—United States, 2000–2005,” Journal of Infectious Diseases, vol. 201, no. 8, pp. 1208–1224, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. P. van der Ley, L. Steeghs, H. J. Hamstra, J. Ten Hove, B. Zomer, and L. Van Alphen, “Modification of lipid a biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity,” Infection and Immunity, vol. 69, no. 10, pp. 5981–5990, 2001. View at Publisher · View at Google Scholar · View at Scopus
  89. J. C. Dunning Hotopp, R. Grifantini, N. Kumar et al., “Comparative genomics of Neisseria meningitidis: core genome, islands of horizontal transfer and pathogen-specific genes,” Microbiology, vol. 152, no. 12, pp. 3733–3749, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. H. Lo, C. M. Tang, and R. M. Exley, “Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development,” The Lancet Infectious Diseases, vol. 9, no. 7, pp. 418–427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. M. C. Schneider, B. E. Prosser, J. J. E. Caesar et al., “Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates,” Nature, vol. 458, no. 7240, pp. 890–893, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Lappann, S. Danhof, F. Guenther, S. Olivares-Florez, I. L. Mordhorst, and U. Vogel, “In vitro resistance mechanisms of Neisseria meningitidis against neutrophil extracellular traps,” Molecular Microbiology, vol. 89, no. 3, pp. 433–449, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. M. Stork, J. Grijpstra, M. P. Bos et al., “Zinc piracy as a mechanism of Neisseria meningitidis for evasion of nutritional immunity,” PLoS Pathogens, vol. 9, no. 10, Article ID e1003733, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Saleem, S. M. Prince, S. E. J. Rigby et al., “Use of a molecular decoy to segregate transport from antigenicity in the FrpB iron transporter from Neisseria meningitides,” PLoS ONE, vol. 8, no. 2, Article ID e56746, 2013. View at Publisher · View at Google Scholar · View at Scopus
  95. K. Hubert, M.-C. Pawlik, H. Claus, H. Jarva, S. Meri, and U. Vogel, “Opc expression, LPS immunotype switch and pilin conversion contribute to serum resistance of unencapsulated meningococci,” PLoS ONE, vol. 7, no. 9, Article ID e45132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. C. M. Tsai, R. Boykins, and C. E. Frasch, “Heterogeneity and variation among Neisseria meningitidis lipopolysaccharides,” Journal of Bacteriology, vol. 155, no. 2, pp. 498–504, 1983. View at Google Scholar · View at Scopus
  97. J. Chamot-Rooke, G. Mikaty, C. Malosse et al., “Posttranslational modification of pili upon cell contact triggers N. meningitidis dissemination,” Science, vol. 331, no. 6018, pp. 778–782, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. F. E.-C. Jen, C. E. Jones, J. C. Wilson, B. L. Schulz, and M. P. Jennings, “Substrate recognition of a structure motif for phosphorylcholine post-translational modification in Neisseria meningitidis,” Biochemical and Biophysical Research Communications, vol. 431, no. 4, pp. 808–814, 2013. View at Publisher · View at Google Scholar · View at Scopus
  99. E. Loh, E. Kugelberg, A. Tracy et al., “Temperature triggers immune evasion by Neisseria meningitidis,” Nature, vol. 502, no. 7470, pp. 237–240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  100. M. F. Anjum, T. M. Stevanin, R. C. Read, and J. W. B. Moir, “Nitric oxide metabolism in Neisseria meningitidis,” Journal of Bacteriology, vol. 184, no. 11, pp. 2987–2993, 2002. View at Publisher · View at Google Scholar · View at Scopus
  101. P. Stefanelli, G. Colotti, A. Neri et al., “Molecular characterization of nitrite reductase gene (aniA) and gene product in Neisseria meningitidis isolates: is aniA essential for meningococcal survival?” IUBMB Life, vol. 60, no. 9, pp. 629–636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. H. Echenique-Rivera, A. Muzzi, E. del Tordello et al., “Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival,” PLoS Pathogens, vol. 7, no. 5, Article ID e1002027, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. H. A. Hadi, K. G. Wooldridge, K. Robinson, and D. A. A. Ala'Aldeen, “Identification and characterization of App: an immunogenic autotransporter protein of Neisseria meningitidis,” Molecular Microbiology, vol. 41, no. 3, pp. 611–623, 2001. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Arenas, S. Cano, R. Nijland et al., “The meningococcal autotransporter AutA is implicated in autoaggregation and biofilm formation,” Environmental Microbiology, vol. 17, no. 4, pp. 1321–1337, 2015. View at Publisher · View at Google Scholar
  105. N. H. Chen, R. M. Couñago, K. Y. Djoko et al., “A glutathione-dependent detoxification system is required for formaldehyde resistance and optimal survival of neisseria meningitidis in biofilms,” Antioxidants and Redox Signaling, vol. 18, no. 7, pp. 743–755, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. R. B. Neil and M. A. Apicella, “Role of HrpA in biofilm formation of Neisseria meningitidis and regulation of the hrpBAS transcripts,” Infection and Immunity, vol. 77, no. 6, pp. 2285–2293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. A. J. Potter, S. P. Kidd, M. P. Jennings, and A. G. McEwan, “Evidence for distinctive mechanisms of S-nitrosoglutathione metabolism by AdhC in two closely related species, Neisseria gonorrhoeae and Neisseria meningitidis,” Infection and Immunity, vol. 75, no. 3, pp. 1534–1536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. K. Yi, A. W. Rasmussen, S. K. Gudlavalleti, D. S. Stephens, and I. Stojiljkovic, “Biofilm formation by Neisseria meningitidis,” Infection and Immunity, vol. 72, no. 10, pp. 6132–6138, 2004. View at Publisher · View at Google Scholar · View at Scopus
  109. S. Agarwal, S. Vasudhev, R. B. DeOliveira, and S. Ram, “Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides,” The Journal of Immunology, vol. 193, no. 4, pp. 1855–1863, 2014. View at Publisher · View at Google Scholar
  110. A. C. Pridmore, D. H. Wyllie, F. Abdillahi et al., “A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2,” The Journal of Infectious Diseases, vol. 183, no. 1, pp. 89–96, 2001. View at Publisher · View at Google Scholar
  111. L. M. Willis and C. Whitfield, “KpsC and KpsS are retaining 3-deoxy-D-manno-oct-2- ulosonic acid (Kdo) transferases involved in synthesis of bacterial capsules,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 51, pp. 20753–20758, 2013. View at Publisher · View at Google Scholar · View at Scopus
  112. T. R. Sampson and D. S. Weiss, “CRISPR-Cas systems: new players in gene regulation and bacterial physiology,” Frontiers in Cellular and Infection Microbiology, vol. 4, p. 37, 2014. View at Publisher · View at Google Scholar
  113. K. M. Esvelt, P. Mali, J. L. Braff, M. Moosburner, S. J. Yaung, and G. M. Church, “Orthogonal Cas9 proteins for RNA-guided gene regulation and editing,” Nature Methods, vol. 10, no. 11, pp. 1116–1123, 2013. View at Publisher · View at Google Scholar · View at Scopus
  114. E. Kugelberg, B. Gollan, and C. M. Tang, “Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing,” Vaccine, vol. 26, supplement 8, pp. I34–I39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  115. A. E. Deghmane, D. Giorgini, M. Larribe, J.-M. Alonso, and M.-K. Taha, “Down-regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein,” Molecular Microbiology, vol. 43, no. 6, pp. 1555–1564, 2002. View at Publisher · View at Google Scholar · View at Scopus
  116. R. Ieva, C. Alaimo, I. Delany, G. Spohn, R. Rappuoli, and V. Scarlato, “CrgA is an inducible LysR-type regulator of Neisseria meningitidis, acting both as a repressor and as an activator of gene transcription,” Journal of Bacteriology, vol. 187, no. 10, pp. 3421–3430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  117. K. O. Johswich, J. Zhou, D. K. S. Law et al., “Invasive potential of nonencapsulated disease isolates of Neisseria meningitides,” Infection and Immunity, vol. 80, no. 7, pp. 2346–2353, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. M. J. Uria, Q. Zhang, Y. Li et al., “A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies,” Journal of Experimental Medicine, vol. 205, no. 6, pp. 1423–1434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  119. T. M. Stevanin, J. R. Laver, R. K. Poole, J. W. B. Moir, and R. C. Read, “Metabolism of nitric oxide by Neisseria meningitidis modifies release of NO-regulated cytokines and chemokines by human macrophages,” Microbes and Infection, vol. 9, no. 8, pp. 981–987, 2007. View at Publisher · View at Google Scholar · View at Scopus
  120. T. M. Stevanin, J. W. B. Moir, and R. C. Read, “Nitric oxide detoxification systems enhance survival of Neisseria meningitidis in human macrophages and in nasopharyngeal mucosa,” Infection and Immunity, vol. 73, no. 6, pp. 3322–3329, 2005. View at Publisher · View at Google Scholar · View at Scopus
  121. T. Davidsen, E. K. Amundsen, E. A. Rødland, and T. Tønjum, “DNA repair profiles of disease-associated isolates of Neisseria meningitidis,” FEMS Immunology and Medical Microbiology, vol. 49, no. 2, pp. 243–251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. A. K. Criss and H. S. Seifert, “A bacterial siren song: intimate interactions between Neisseria and neutrophils,” Nature Reviews Microbiology, vol. 10, no. 3, pp. 178–190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  123. S. Schielke, C. Spatz, R. F. Schwarz et al., “Characterization of FarR as a highly specialized, growth phase-dependent transcriptional regulator in Neisseria meningitidis,” International Journal of Medical Microbiology, vol. 301, no. 4, pp. 325–333, 2011. View at Publisher · View at Google Scholar · View at Scopus
  124. J. Kortekaas, S. A. Müller, P. Ringler et al., “Immunogenicity and structural characterisation of an in vitro folded meningococcal siderophore receptor (FrpB, FetA),” Microbes and Infection, vol. 8, no. 8, pp. 2145–2153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  125. J. Kortekaas, A. Pettersson, J. van der Biezen et al., “Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region,” Vaccine, vol. 25, no. 1, pp. 72–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  126. K. O. Mironov, A. E. Platonov, I. S. Koroleva et al., “Monitoring for Neisseria meningitidis species using sequencing of variable fragments of surface proteins FetA and PorA genes,” Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii, no. 3, pp. 23–27, 2009. View at Google Scholar · View at Scopus
  127. J. A. Welsch and S. Ram, “Factor H and Neisserial pathogenesis,” Vaccine, vol. 26, no. 8, pp. I40–I45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  128. P. van der Ley, J. van der Biezen, R. Sutmuller, P. Hoogerhout, and J. T. Poolman, “Sequence variability of FrpB, a major iron-regulated outer-membrane protein in the pathogenic neisseriae,” Microbiology, vol. 142, no. 11, pp. 3269–3274, 1996. View at Publisher · View at Google Scholar · View at Scopus
  129. I. Delany, R. Rappuoli, and V. Scarlato, “Fur functions as an activator and as a repressor of putative virulence genes in Neisseria meningitidis,” Molecular Microbiology, vol. 52, no. 4, pp. 1081–1090, 2004. View at Publisher · View at Google Scholar · View at Scopus
  130. H. Takahashi, K. Hirose, and H. Watanabe, “Necessity of meningococcal γ-glutamyl aminopeptidase for Neisseria meningitidis growth in rat cerebrospinal fluid (CSF) and CSF-like medium,” Journal of Bacteriology, vol. 186, no. 1, pp. 244–247, 2004. View at Publisher · View at Google Scholar · View at Scopus
  131. A. W. Rasmussen, H. L. Alexander, D. Perkins-Balding, W. M. Shafer, and I. Stojiljkovic, “Resistance of Neisseria meningitidis to the toxic effects of heme iron and other hydrophobic agents requires expression of ght,” Journal of Bacteriology, vol. 187, no. 15, pp. 5214–5223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  132. F. Putker, A. Grutsch, J. Tommassen, and M. P. Bos, “Ght protein of neisseria meningitidis is involved in the regulation of lipopolysaccharide biosynthesis,” Journal of Bacteriology, vol. 196, no. 4, pp. 780–789, 2014. View at Publisher · View at Google Scholar · View at Scopus
  133. R. Colicchio, S. Ricci, F. Lamberti et al., “The meningococcal ABC-type L-glutamate transporter GltT is necessary for the development of experimental meningitis in mice,” Infection and Immunity, vol. 77, no. 9, pp. 3578–3587, 2009. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Talà, C. Monaco, K. Nagorska et al., “Glutamate utilization promotes meningococcal survival in vivo through avoidance of the neutrophil oxidative burst,” Molecular Microbiology, vol. 81, no. 5, pp. 1330–1342, 2011. View at Publisher · View at Google Scholar · View at Scopus
  135. C. S. Hong, W. Hashimoto, A. M. Fialho, T. K. Das Gupta, and A. M. Chakrabarty, “Disrupting the entry barrier and attacking brain tumors: the role of the Neisseria H.8 epitope and the Laz protein,” Cell Cycle, vol. 5, no. 15, pp. 1633–1641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  136. W. Baehr, E. C. Gotschlich, and P. J. Hitchcock, “The virulence-associated gonococcal H.8 gene encodes 14 tandemly repeated pentapeptides,” Molecular Microbiology, vol. 3, no. 1, pp. 49–55, 1989. View at Publisher · View at Google Scholar · View at Scopus
  137. J. R. Black, W. J. Black, and J. G. Cannon, “Neisserial antigen H.8 is immunogenic in patients with disseminated gonococcal and meningococcal infections,” Journal of Infectious Diseases, vol. 151, no. 4, pp. 650–657, 1985. View at Publisher · View at Google Scholar · View at Scopus
  138. T. D. Ray, L. A. Lewis, S. Gulati, P. A. Rice, and S. Ram, “Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitidis Lip/H.8 and Laz lipoproteins,” Journal of Immunology, vol. 186, no. 8, pp. 4881–4894, 2011. View at Publisher · View at Google Scholar · View at Scopus
  139. I. Tauseef, O. B. Harrison, K. G. Wooldridge et al., “Influence of the combination and phase variation status of the haemoglobin receptors HmbR and HpuAB on meningococcal virulence,” Microbiology, vol. 157, no. 5, pp. 1446–1456, 2011. View at Publisher · View at Google Scholar · View at Scopus
  140. J. Lucidarme, J. Findlow, H. Chan et al., “The distribution and ‘in vivo’ phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysis,” PLoS ONE, vol. 8, no. 9, Article ID e76932, 2013. View at Publisher · View at Google Scholar · View at Scopus
  141. H. Omer, G. Rose, K. A. Jolley et al., “Genotypic and phenotypic modifications of Neisseria meningitidis after an accidental human passage,” PLoS ONE, vol. 6, no. 2, Article ID e17145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  142. L. Fantappiè, M. M. E. Metruccio, K. L. Seib et al., “The RNA chaperone Hfq is involved in stress response and virulence in Neisseria meningitidis and is a pleiotropic regulator of protein expression,” Infection and Immunity, vol. 77, no. 5, pp. 1842–1853, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. S. Vitovski, R. C. Read, and J. R. Sayers, “Invasive isolates of Neisseria meningitidis possess enhanced immunoglobulin A1 protease activity compared to colonizing strains,” The FASEB Journal, vol. 13, no. 2, pp. 331–337, 1999. View at Google Scholar · View at Scopus
  144. S. A. Spence, V. L. Clark, and V. M. Isabella, “The role of catalase in gonococcal resistance to peroxynitrite,” Microbiology, vol. 158, no. 2, pp. 560–570, 2012. View at Publisher · View at Google Scholar · View at Scopus
  145. H.-J. Wu, K. L. Seib, J. L. Edwards, M. A. Apicella, A. G. McEwan, and M. P. Jennings, “Azurin of pathogenic Neisseria spp. is involved in defense against hydrogen peroxide and survival within cervical epithelial cells,” Infection and Immunity, vol. 73, no. 12, pp. 8444–8448, 2005. View at Publisher · View at Google Scholar · View at Scopus
  146. V. Roussel-Jazédé, I. Jongerius, M. P. Bos, J. Tommassen, and P. Van Ulsen, “NalP-mediated proteolytic release of lactoferrin-binding protein B from the meningococcal cell surface,” Infection and Immunity, vol. 78, no. 7, pp. 3083–3089, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. R. Exley, M. Winterbotham, Q. Zhang, V. Pelicic, and C. M. Tang, “A Conserved Major Pilin subunit in Neisseria meningitidis,” http://www.meningitis.org/assets/x/52309.
  148. S. A. Brown, K. L. Palmer, and M. Whiteley, “Revisiting the host as a growth medium,” Nature Reviews Microbiology, vol. 6, no. 9, pp. 657–666, 2008. View at Publisher · View at Google Scholar · View at Scopus
  149. S. Piek, Z. Wang, J. Ganguly et al., “The role of oxidoreductases in determining the function of the neisserial lipid a phosphoethanolamine transferase required for resistance to polymyxin,” PLoS ONE, vol. 9, no. 9, Article ID e106513, 2014. View at Publisher · View at Google Scholar
  150. R. S. W. Tsang, D. K. S. Law, C.-M. Tsai, and L.-K. Ng, “Detection of the 1st gene in different serogroups and LOS immunotypes of Neisseria meningitidis,” FEMS Microbiology Letters, vol. 199, no. 2, pp. 203–206, 2001. View at Publisher · View at Google Scholar · View at Scopus
  151. N. J. Griffiths, D. J. Hill, E. Borodina et al., “Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance,” Molecular Microbiology, vol. 82, no. 5, pp. 1129–1149, 2011. View at Publisher · View at Google Scholar · View at Scopus
  152. M. K. Bielecka, N. Devos, M. Gilbert et al., “Recombinant protein truncation strategy for inducing bactericidal antibodies to the macrophage infectivity potentiator protein of Neisseria meningitidis and circumventing potential cross-reactivity with human FK506-binding proteins,” Infection and Immunity, vol. 83, no. 2, pp. 730–742, 2015. View at Publisher · View at Google Scholar
  153. N. Tsolakos, C. Brookes, S. Taylor et al., “Identification of vaccine antigens using integrated proteomic analyses of surface immunogens from serogroup B Neisseria meningitidis,” Journal of Proteomics, vol. 101, pp. 63–76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  154. Y.-L. Tzeng, A. Datta, K. Ambrose et al., “The MisR/MisS two-component regulatory system influences inner core structure and immunotype of lipooligosaccharide in Neisseria meningitidis,” The Journal of Biological Chemistry, vol. 279, no. 33, pp. 35053–35062, 2004. View at Publisher · View at Google Scholar · View at Scopus
  155. J. Adu-Bobie, P. Lupetti, B. Brunelli et al., “GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence,” Infection and Immunity, vol. 72, no. 4, pp. 1914–1919, 2004. View at Publisher · View at Google Scholar · View at Scopus
  156. K. L. Seib, H.-J. Tseng, A. G. McEwan, M. A. Apicella, and M. P. Jennings, “Defenses against oxidative stress in Neisseria gonorrhoeae and Neisseria meningitidis: distinctive systems for different lifestyles,” The Journal of Infectious Diseases, vol. 190, no. 1, pp. 136–147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  157. M. Antoine, A. Gand, S. Boschi-Muller, and G. Branlant, “Characterization of the amino acids from Neisseria meningitidis MsrA involved in the chemical catalysis of the methionine sulfoxide reduction step,” The Journal of Biological Chemistry, vol. 281, no. 51, pp. 39062–39070, 2006. View at Publisher · View at Google Scholar · View at Scopus
  158. Y.-L. Tzeng, K. D. Ambrose, S. Zughaier et al., “Cationic antimicrobial peptide resistance in Neisseria meningitidis,” Journal of Bacteriology, vol. 187, no. 15, pp. 5387–5396, 2005. View at Publisher · View at Google Scholar · View at Scopus
  159. R. M. Delahay, B. D. Robertson, J. T. Balthazar, W. M. Shafer, and C. A. Ison, “Involvement of the gonococcal MtrE protein in the resistance of Neisseria gonorrhoeae to toxic hydrophobic agents,” Microbiology, vol. 143, no. 7, pp. 2127–2133, 1997. View at Publisher · View at Google Scholar · View at Scopus
  160. M. Comanducci, S. Bambini, B. Brunelli et al., “NadA, a novel vaccine candidate of Neisseria meningitidis,” The Journal of Experimental Medicine, vol. 195, no. 11, pp. 1445–1454, 2002. View at Publisher · View at Google Scholar · View at Scopus
  161. B. Capecchi, J. Adu-Bobie, F. di Marcello et al., “Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells,” Molecular Microbiology, vol. 55, no. 3, pp. 687–698, 2005. View at Publisher · View at Google Scholar · View at Scopus
  162. C. Mazzon, B. Baldani-Guerra, P. Cecchini et al., “IFN-γ and R-848 dependent activation of human monocyte-derived dendritic cells by Neisseria meningitidis adhesin A,” The Journal of Immunology, vol. 179, no. 6, pp. 3904–3916, 2007. View at Publisher · View at Google Scholar · View at Scopus
  163. G. Bozza, M. Capitani, P. Montanari et al., “Role of ARF6, Rab11 and external Hsp90 in the trafficking and recycling of recombinant-soluble neisseria meningitidis adhesin A (rNadA) in human epithelial cells,” PLoS ONE, vol. 9, no. 10, Article ID e110047, 2014. View at Publisher · View at Google Scholar
  164. V. Nägele, J. Heesemann, S. Schielke, L. F. Jiménez-Soto, O. Kurzai, and N. Ackermann, “Neisseria meningitidis adhesin NadA targets beta1 integrins: functional similarity to Yersinia invasion,” The Journal of Biological Chemistry, vol. 286, no. 23, pp. 20536–20546, 2011. View at Publisher · View at Google Scholar · View at Scopus
  165. S. Franzoso, C. Mazzon, M. Sztukowska et al., “Human monocytes/macrophages are a target of Neisseria meningitidis Adhesin A (NadA),” Journal of Leukocyte Biology, vol. 83, no. 5, pp. 1100–1110, 2008. View at Publisher · View at Google Scholar · View at Scopus
  166. P. van Ulsen, L. van Alphen, J. ten Hove, F. Fransen, P. van der Ley, and J. Tommassen, “A Neisserial autotransporter NalP modulating the processing of other autotransporters,” Molecular Microbiology, vol. 50, no. 3, pp. 1017–1030, 2003. View at Publisher · View at Google Scholar · View at Scopus
  167. S. Bambini, J. Piet, A. Muzzi et al., “An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands,” PLoS ONE, vol. 8, no. 5, Article ID e65043, 2013. View at Publisher · View at Google Scholar · View at Scopus
  168. I. R. Peak, Y. N. Srikhanta, V. E. Weynants, C. Feron, J. T. Poolman, and M. P. Jennings, “Evaluation of truncated NhhA protein as a candidate meningococcal vaccine antigen,” PLoS ONE, vol. 8, no. 9, Article ID e72003, 2013. View at Publisher · View at Google Scholar · View at Scopus
  169. H. Sjölinder and A.-B. Jonsson, “Imaging of disease dynamics during meningococcal sepsis,” PLoS ONE, vol. 2, no. 2, article e241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  170. K. R. Barth, V. M. Isabella, and V. L. Clark, “Biochemical and genomic analysis of the denitrification pathway within the genus Neisseria,” Microbiology, vol. 155, no. 12, pp. 4093–4103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  171. M. Aspholm, F. E. Aas, O. B. Harrison et al., “Structural alterations in a component of cytochrome c oxidase and molecular evolution of pathogenic Neisseria in humans,” PLoS Pathogens, vol. 6, no. 8, Article ID e1001055, pp. 55–56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  172. J. R. Laver, T. M. Stevanin, S. L. Messenger et al., “Bacterial nitric oxide detoxification prevents host cell S-nitrosothiol formation: a novel mechanism of bacterial pathogenesis,” The FASEB Journal, vol. 24, no. 1, pp. 286–295, 2010. View at Publisher · View at Google Scholar · View at Scopus
  173. S. Chandra, D. Singh, and T. R. Singh, “Prediction and characterization of T-cell epitopes for epitope vaccine design from outer membrane protein of Neisseria meningitidis serogroup B,” Bioinformation, vol. 5, no. 4, pp. 155–161, 2010. View at Publisher · View at Google Scholar
  174. S. Giuntini, D. M. Vu, and D. M. Granoff, “FH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations,” Vaccine, vol. 31, no. 38, pp. 4192–4199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  175. L. A. Lewis, D. M. Vu, D. M. Granoff, and S. Ram, “Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model,” Infection and Immunity, vol. 82, no. 6, pp. 2574–2584, 2014. View at Publisher · View at Google Scholar · View at Scopus
  176. J. D. Rock, M. J. Thomson, R. C. Read, and J. W. B. Moir, “Regulation of denitrification genes in Neisseria meningitidis by nitric oxide and the repressor NsrR,” Journal of Bacteriology, vol. 189, no. 3, pp. 1138–1144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  177. K. Heurlier, M. J. Thomson, N. Aziz, and J. W. B. Moir, “The nitric oxide (NO)-sensing repressor NsrR of Neisseria meningitidis has a compact regulon of genes involved in NO synthesis and detoxification,” Journal of Bacteriology, vol. 190, no. 7, pp. 2488–2495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  178. H. J. Lee, B. Rakić, M. Gilbert, W. W. Wakarchuk, S. G. Withers, and N. C. J. Strynadka, “Structural and kinetic characterizations of the polysialic acid O-acetyltransferase OatWY from Neisseria meningitidis,” Journal of Biological Chemistry, vol. 284, no. 36, pp. 24501–24511, 2009. View at Publisher · View at Google Scholar · View at Scopus
  179. M. Sadarangani, A. J. Pollard, and S. D. Gray-Owen, “Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria,” FEMS Microbiology Reviews, vol. 35, no. 3, pp. 498–514, 2011. View at Publisher · View at Google Scholar · View at Scopus
  180. M. J. Callaghan, C. Buckee, N. D. McCarthy et al., “Opa protein repertoires of disease-causing and carried meningococci,” Journal of Clinical Microbiology, vol. 46, no. 9, pp. 3033–3041, 2008. View at Publisher · View at Google Scholar · View at Scopus
  181. E. Carbonnelle, D. J. Hill, P. Morand et al., “Meningococcal interactions with the host,” Vaccine, vol. 27, supplement 2, pp. B78–B89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  182. K. O. Johswich, S. E. McCaw, E. Islam et al., “In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa,” PLoS Pathogens, vol. 9, no. 7, Article ID e1003509, 2013. View at Publisher · View at Google Scholar · View at Scopus
  183. H. A. Rowe, N. J. Griffiths, D. J. Hill, and M. Virji, “Co-ordinate action of bacterial adhesins and human carcinoembryonic antigen receptors in enhanced cellular invasion by capsulate serum resistant Neisseria meningitidis,” Cellular Microbiology, vol. 9, no. 1, pp. 154–168, 2007. View at Publisher · View at Google Scholar · View at Scopus
  184. K. Wolff and A. Stern, “Identification and characterization of specific sequences encoding pathogenicity associated proteins in the genome of commensal Neisseria species,” FEMS Microbiology Letters, vol. 125, no. 2-3, pp. 255–263, 1995. View at Publisher · View at Google Scholar · View at Scopus
  185. M. M. Eason and X. Fan, “The role and regulation of catalase in respiratory tract opportunistic bacterial pathogens,” Microbial Pathogenesis, vol. 74, pp. 50–58, 2014. View at Publisher · View at Google Scholar
  186. R. Ieva, D. Roncarati, M. M. E. Metruccio, K. L. Seib, V. Scarlato, and I. Delany, “OxyR tightly regulates catalase expression in Neisseria meningitidis through both repression and activation mechanisms,” Molecular Microbiology, vol. 70, no. 5, pp. 1152–1165, 2008. View at Publisher · View at Google Scholar · View at Scopus
  187. C. Dehio, S. D. Gray-Owen, and T. F. Meyer, “Host cell invasion by pathogenic Neisseriae,” Sub-Cellular Biochemistry, vol. 33, pp. 61–96, 2000. View at Google Scholar · View at Scopus
  188. J. P. Dillard and K. T. Hackett, “Mutations affecting peptidoglycan acetylation in Neisseria gonorrhoeae and Neisseria meningitidis,” Infection and Immunity, vol. 73, no. 9, pp. 5697–5705, 2005. View at Publisher · View at Google Scholar · View at Scopus
  189. I. Linhartova, M. Basler, J. Ichikawa et al., “Meningococcal adhesion suppresses proapoptotic gene expression and promotes expression of genes supporting early embryonic and cytoprotective signaling of human endothelial cells,” FEMS Microbiology Letters, vol. 263, no. 1, pp. 109–118, 2006. View at Publisher · View at Google Scholar · View at Scopus
  190. H. Takahashi, T. Yanagisawa, K. S. Kim, S. Yokoyama, and M. Ohnishi, “Meningococcal pilV potentiates Neisseria meningitidis type IV pilus-mediated internalization into human endothelial and epithelial cells,” Infection and Immunity, vol. 80, no. 12, pp. 4154–4166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  191. S. C. Bernard, N. Simpson, O. Join-Lambert et al., “Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization,” Nature Medicine, vol. 20, no. 7, pp. 725–731, 2014. View at Publisher · View at Google Scholar · View at Scopus
  192. S. V. Balasingham, R. F. Collins, R. Assalkhou et al., “Interactions between the lipoprotein PilP and the secretin PilQ in Neisseria meningitidis,” Journal of Bacteriology, vol. 189, no. 15, pp. 5716–5727, 2007. View at Publisher · View at Google Scholar · View at Scopus
  193. S. K. Dash, M. Sharma, S. Khare, and A. Kumar, “rmpM Gene as a genetic marker for human bacterial meningitis,” Cellular and Molecular Biology, vol. 58, no. 1, pp. 26–30, 2012. View at Publisher · View at Google Scholar · View at Scopus
  194. A. Hey, M.-S. Li, M. J. Hudson, P. R. Langford, and J. Simon Krolla, “Transcriptional profiling of Neisseria meningitidis interacting with human epithelial cells in a long-term in vitro colonization model,” Infection and Immunity, vol. 81, no. 11, pp. 4149–4159, 2013. View at Publisher · View at Google Scholar · View at Scopus
  195. R. Grifantini, E. Frigimelica, I. Delany et al., “Characterization of a novel Neisseria meningitidis Fur and iron-regulated operon required for protection from oxidative stress: utility of DNA microarray in the assignment of the biological role of hypothetical genes,” Molecular Microbiology, vol. 54, no. 4, pp. 962–979, 2004. View at Publisher · View at Google Scholar · View at Scopus
  196. R. Gasparini, D. Amicizia, P. L. Lai, and D. Panatto, “Neisseria meningitidis: pathogenetic mechanisms to overcome the human immune defences,” Journal of Preventive Medicine and Hygiene, vol. 53, no. 2, pp. 50–55, 2012. View at Google Scholar · View at Scopus
  197. A. Unkmeir, U. Kämmerer, A. Stade et al., “Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells,” Infection and Immunity, vol. 70, no. 5, pp. 2454–2462, 2002. View at Publisher · View at Google Scholar · View at Scopus
  198. M. R. Spinosa, C. Progida, A. Talà, L. Cogli, P. Alifano, and C. Bucci, “The Neisseria meningitidis capsule is important for intracellular survival in human cells,” Infection and Immunity, vol. 75, no. 7, pp. 3594–3603, 2007. View at Publisher · View at Google Scholar · View at Scopus
  199. A. Talà, L. Cogli, M. D. Stefano et al., “Serogroup-specific interaction of Neisseria meningitidis capsular polysaccharide with host cell microtubules and effects on tubulin polymerization,” Infection and Immunity, vol. 82, no. 1, pp. 265–274, 2014. View at Publisher · View at Google Scholar · View at Scopus
  200. D. J. Hill, N. J. Griffiths, E. Borodina, and M. Virji, “Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease,” Clinical Science, vol. 118, no. 9, pp. 547–564, 2010. View at Google Scholar · View at Scopus
  201. M. Drogari-Apiranthitou, E. J. Kuijper, N. Dekker, and J. Dankert, “Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity,” Infection and Immunity, vol. 70, no. 7, pp. 3752–3758, 2002. View at Publisher · View at Google Scholar · View at Scopus
  202. S. Ram, F. G. Mackinnon, S. Gulati et al., “The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis,” Molecular Immunology, vol. 36, no. 13-14, pp. 915–928, 1999. View at Publisher · View at Google Scholar · View at Scopus
  203. M. J. Simões, M. Cunha, F. Almeida, C. Furtado, and L. Brum, “Molecular surveillance of Neisseria meningitidis capsular switching in Portugal, 2002–2006,” Epidemiology and Infection, vol. 137, no. 2, pp. 161–165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  204. L. Craig, N. Volkmann, A. S. Arvai et al., “Type IV pilus structure by cryo-electron microscopy and crystallography: implications for pilus assembly and functions,” Molecular Cell, vol. 23, no. 5, pp. 651–662, 2006. View at Publisher · View at Google Scholar · View at Scopus
  205. M. Kirchner and T. F. Meyer, “The PilC adhesin of the Neisseria type IV pilus—binding specificities and new insights into the nature of the host cell receptor,” Molecular Microbiology, vol. 56, no. 4, pp. 945–957, 2005. View at Publisher · View at Google Scholar · View at Scopus
  206. C. J. Orihuela, J. Mahdavi, J. Thornton et al., “Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models,” Journal of Clinical Investigation, vol. 119, no. 6, pp. 1638–1646, 2009. View at Publisher · View at Google Scholar · View at Scopus
  207. J. L. Diaz, M. Virji, and J. E. Heckels, “Structural and antigenic differences between two types of meningococcal pili,” FEMS Microbiology Letters, vol. 21, no. 2, pp. 181–184, 1984. View at Publisher · View at Google Scholar · View at Scopus
  208. R. A. Helm and H. S. Seifert, “Frequency and rate of pilin antigenic variation of Neisseria meningitidis,” Journal of Bacteriology, vol. 192, no. 14, pp. 3822–3823, 2010. View at Publisher · View at Google Scholar · View at Scopus
  209. M. E. Wörmann, C. L. Horien, J. S. Bennett et al., “Sequence, distribution and chromosomal context of class I and class II pilin genes of Neisseria meningitidis identified in whole genome sequences,” BMC Genomics, vol. 15, no. 1, article 253, 2014. View at Publisher · View at Google Scholar · View at Scopus
  210. E. Carbonnelle, S. Helaine, X. Nassif, and V. Pelicic, “A systematic genetic analysis in Neisseria meningitidis defines the Pil proteins required for assembly, functionality, stabilization and export of type IV pili,” Molecular Microbiology, vol. 61, no. 6, pp. 1510–1522, 2006. View at Publisher · View at Google Scholar · View at Scopus
  211. M. Kirchner, D. Heuer, and T. F. Meyer, “CD46-independent binding of neisserial type IV pili and the major pilus adhesin, PilC, to human epithelial cells,” Infection and Immunity, vol. 73, no. 5, pp. 3072–3082, 2005. View at Publisher · View at Google Scholar · View at Scopus
  212. M. Coureuil, H. Lécuyer, M. G. H. Scott et al., “Meningococcus hijacks a β2-adrenoceptor/β-arrestin pathway to cross brain microvasculature endothelium,” Cell, vol. 143, no. 7, pp. 1149–1160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  213. T. Brissac, G. Mikaty, G. Duménil, M. Coureuil, and X. Nassif, “The meningococcal minor pilin PilX is responsible for type IV pilus conformational changes associated with signaling to endothelial cells,” Infection and Immunity, vol. 80, no. 9, pp. 3297–3306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  214. M. Virji, S. M. Watt, S. Barker, K. Makepeace, and R. Doyonnas, “The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae,” Molecular Microbiology, vol. 22, no. 5, pp. 929–939, 1996. View at Publisher · View at Google Scholar · View at Scopus
  215. E. R. Watkins, Y. H. Grad, S. Gupta, and C. O. Buckee, “Contrasting within- and between-host immune selection shapes Neisseria Opa repertoires,” Scientific Reports, vol. 4, Article ID e6554, 2014. View at Publisher · View at Google Scholar
  216. R. Leuzzi, L. Serino, D. Serruto, and M. Pizza, “Newly described surface structures and adhesion strategies of the pathogenic Neisseriae,” in Neisseria: Molecular Mechanisms of Pathogenesis, Caister Academic Press, Norfolk, UK, 2010. View at Google Scholar
  217. J. Pohlner, R. Halter, and T. F. Meyer, “Neisseria gonorrhoeae IgA protease. Secretion and implications for pathogenesis,” Antonie van Leeuwenhoek, vol. 53, no. 6, pp. 479–484, 1987. View at Publisher · View at Google Scholar · View at Scopus
  218. D. P. J. Turner, A. G. Marietou, L. Johnston et al., “Characterization of MspA, an immunogenic autotransporter protein that mediates adhesion to epithelial and endothelial cells in Neisseria meningitidis,” Infection and Immunity, vol. 74, no. 5, pp. 2957–2964, 2006. View at Publisher · View at Google Scholar · View at Scopus
  219. M. Sjölinder, G. Altenbacher, M. Hagner, W. Sun, S. Schedin-Weiss, and H. Sjölinder, “Meningococcal outer membrane protein NhhA triggers apoptosis in macrophages,” PLoS ONE, vol. 7, no. 1, Article ID e29586, 2012. View at Publisher · View at Google Scholar · View at Scopus
  220. V. Nägele, J. Heesemann, S. Schielke, L. F. Jiménez-Soto, O. Kurzai, and N. Ackermann, “Neisseria meningitidis adhesin NadA targets β1 integrins: functional similarity to Yersinia invasion,” The Journal of Biological Chemistry, vol. 286, no. 23, pp. 20536–20546, 2011. View at Publisher · View at Google Scholar
  221. F. S. Archibald and M. N. Duong, “Superoxide dismutase and oxygen toxicity defenses in the genus Neisseria,” Infection and Immunity, vol. 51, no. 2, pp. 631–641, 1986. View at Google Scholar · View at Scopus
  222. S. Sainsbury, J. Ren, J. E. Nettleship, N. J. Saunders, D. I. Stuart, and R. J. Owens, “The structure of a reduced form of OxyR from Neisseria meningitidis,” BMC Structural Biology, vol. 10, article 10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  223. K. E. Wilks, K. L. R. Dunn, J. L. Farrant et al., “Periplasmic superoxide dismutase in meningococcal pathogenicity,” Infection and Immunity, vol. 66, no. 1, pp. 213–217, 1998. View at Google Scholar · View at Scopus
  224. C. Schoen, L. Kischkies, J. Elias, and B. J. Ampattu, “Metabolism and virulence in Neisseria meningitidis,” Frontiers in Cellular and Infection Microbiology, vol. 4, p. 114, 2014. View at Publisher · View at Google Scholar
  225. J. A. Gómez, M. T. Criado, and C. M. Ferreirós, “Cooperation between the components of the meningococcal transferrin receptor, TbpA and TbpB, in the uptake of transferrin iron by the 37-kDa ferric-binding protein (FbpA),” Research in Microbiology, vol. 149, no. 6, pp. 381–387, 1998. View at Publisher · View at Google Scholar · View at Scopus
  226. K. L. R. Dunn, J. L. Farrant, P. R. Langford, and J. S. Kroll, “Bacterial [Cu,Zn]-cofactored superoxide dismutase protects opsonized, encapsulated Neisseria meningitidis from phagocytosis by human monocytes/macrophages,” Infection and Immunity, vol. 71, no. 3, pp. 1604–1607, 2003. View at Publisher · View at Google Scholar · View at Scopus
  227. R. M. Exley, J. Shaw, E. Mowe et al., “Available carbon source influences the resistance of Neisseria meningitidis against complement,” Journal of Experimental Medicine, vol. 201, no. 10, pp. 1637–1645, 2005. View at Publisher · View at Google Scholar · View at Scopus
  228. D. Serruto and C. L. Galeotti, “The signal peptide sequence of a lytic transglycosylase of Neisseria meningitidis is involved in regulation of gene expression,” Microbiology, vol. 150, no. 5, pp. 1427–1437, 2004. View at Publisher · View at Google Scholar · View at Scopus
  229. H. Takahashi, K. S. Kim, and H. Watanabe, “Meningococcal internalization into human endothelial and epithelial cells is triggered by the influx of extracellular L-glutamate via GltT L-glutamate ABC transporter in neisseria meningitidis,” Infection and Immunity, vol. 79, no. 1, pp. 380–382, 2011. View at Publisher · View at Google Scholar · View at Scopus
  230. M. K. Pangburn, V. P. Ferreira, and C. Cortes, “Discrimination between host and pathogens by the complement system,” Vaccine, vol. 26, no. 8, supplement, pp. I15–I21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  231. I. H. Lepow, L. Pillemer, M. D. Schoenberg et al., “The properdin system and immunity. X. Characterization of partially purified human properdin,” Journal of Immunology, vol. 83, pp. 428–436, 1959. View at Google Scholar · View at Scopus
  232. N. A. Cunliffe, N. Snowden, E. M. Dunbar, and M. R. Haeney, “Recurrent meningococcal septicaemia and properdin deficiency,” Journal of Infection, vol. 31, no. 1, pp. 67–68, 1995. View at Publisher · View at Google Scholar · View at Scopus
  233. D. Panatto, D. Amicizia, P. L. Lai, and R. Gasparini, “Neisseria meningitidis B vaccines,” Expert Review of Vaccines, vol. 10, no. 9, pp. 1337–1351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  234. R. Gasparini, D. Amicizia, A. Domnich, P. L. Lai, and D. Panatto, “Neisseria meningitidis B vaccines: recent advances and possible immunization policies,” Expert Review of Vaccines, vol. 13, no. 3, pp. 345–364, 2014. View at Publisher · View at Google Scholar · View at Scopus
  235. D. Panatto, D. Amicizia, P. L. Lai, M. L. Cristina, A. Domnich, and R. Gasparini, “New versus old meningococcal Group B vaccines: how the new ones may benefit infants & toddlers,” Indian Journal of Medical Research, vol. 138, pp. 835–846, 2013. View at Google Scholar · View at Scopus
  236. D. Male, J. Brostoff, D. B. Roth et al., Immunology, Mosby Elsevier, Toronto, Canada, 2006.
  237. A. Gasparoni, L. Ciardelli, A. Avanzini et al., “Age-related changes in intracellular Th1/Th2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults,” Biology of the Neonate, vol. 84, no. 4, pp. 297–303, 2003. View at Publisher · View at Google Scholar · View at Scopus
  238. C. Härtel, N. Adam, T. Strunk, P. Temming, M. Müller-Steinhardt, and C. Schultz, “Cytokine responses correlate differentially with age in infancy and early childhood,” Clinical and Experimental Immunology, vol. 142, no. 3, pp. 446–453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  239. B. Morein, G. Blomqvist, and K. Hu, “Immune responsiveness in the neonatal period,” Journal of Comparative Pathology, vol. 137, no. 1, pp. S27–S31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  240. I. Goldschneider, E. C. Gotschlich, and M. S. Artenstein, “Human immunity to the meningococcus. II. Development of natural immunity,” Journal of Experimental Medicine, vol. 129, no. 6, pp. 1327–1348, 1969. View at Publisher · View at Google Scholar · View at Scopus
  241. S. Flexner, “The results of the serum treatment in thirteen hundred cases of epidemic meningitis,” The Journal of Experimental Medicine, vol. 17, no. 5, pp. 553–576, 1913. View at Publisher · View at Google Scholar
  242. V. Davenport, E. Groves, C. G. Hobbs, N. A. Williams, and R. S. Heyderman, “Regulation of Th-1 T cell-dominated immunity to Neisseria meningitidis within the human mucosa,” Cellular Microbiology, vol. 9, no. 4, pp. 1050–1061, 2007. View at Publisher · View at Google Scholar · View at Scopus
  243. N. A. Korzhueva, D. I. Rybalko, V. P. Naglenko, and A. P. Zinchenko, “Specific immunological reactivity in generalized forms of meningococcal infection in children,” Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, no. 8, pp. 110–114, 1984. View at Google Scholar · View at Scopus
  244. S. Raziuddin, M. E.-H. El-Awad, and N. A. Mir, “Bacterial meningitis: T cell activation and immunoregulatory CD4+ T cell subset alteration,” Journal of Allergy and Clinical Immunology, vol. 87, no. 6, pp. 1115–1120, 1991. View at Publisher · View at Google Scholar · View at Scopus
  245. A. J. Pollard, R. Galassini, E. M. Rouppe van der Voort et al., “Cellular immune responses to Neisseria meningitidis in children,” Infection and Immunity, vol. 67, no. 5, pp. 2452–2463, 1999. View at Google Scholar
  246. A. C. Cruz, B. S. Figueredo, S. L. Souza, M. C. Rebelo, A. G. Carvalho, and L. G. Milagres, “Antibody and memory CD4+ T-cell responses after meningococcal disease,” Vaccine, vol. 32, no. 40, pp. 5145–5148, 2014. View at Publisher · View at Google Scholar
  247. V. Davenport, T. Guthrie, J. Findlow, R. Borrow, N. A. Williams, and R. S. Heyderman, “Evidence for naturally acquired T cell-mediated mucosal immunity to Neisseria meningitidis,” The Journal of Immunology, vol. 171, no. 8, pp. 4263–4270, 2003. View at Publisher · View at Google Scholar · View at Scopus
  248. E. C. Gotschlich, T. Y. Liu, and M. S. Artenstein, “Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides,” The Journal of Experimental Medicine, vol. 129, no. 6, pp. 1349–1365, 1969. View at Publisher · View at Google Scholar · View at Scopus
  249. E. C. Gotschlich, I. Goldschneider, and M. S. Artenstein, “Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers,” Journal of Experimental Medicine, vol. 129, no. 6, pp. 1367–1384, 1969. View at Publisher · View at Google Scholar · View at Scopus
  250. E. C. Gotschlich, I. Goldschneider, and M. S. Artenstein, “Meningococcal infections 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70,” Bulletin of the World Health Organization, vol. 45, Article ID 196970, pp. 279–282, 1971. View at Google Scholar
  251. M. S. Artenstein, “Control of meningococcal meningitis with meningococcal vaccines,” Yale Journal of Biology and Medicine, vol. 48, no. 3, pp. 197–200, 1975. View at Google Scholar · View at Scopus
  252. J. F. Brundage, M. A. K. Ryan, B. H. Feighner, and F. J. Erdtmann, “Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964–1998,” Clinical Infectious Diseases, vol. 35, no. 11, pp. 1376–1381, 2002. View at Publisher · View at Google Scholar · View at Scopus
  253. R. Biselli, A. Fattorossi, P. M. Matricardi, R. Nisini, T. Stroffolini, and R. D'Amelio, “Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination,” Vaccine, vol. 11, no. 5, pp. 578–581, 1993. View at Publisher · View at Google Scholar · View at Scopus
  254. World Health Organization, “International travel and health, ‘Meningococcal disease’,” http://www.who.int/ith/diseases/meningococcal/en/.
  255. K. E. Stein, “Thymus-independent and thymus-dependent responses to polysaccharide antigens,” Journal of Infectious Diseases, vol. 165, supplement 1, pp. S49–S52, 1992. View at Publisher · View at Google Scholar · View at Scopus
  256. J. I. Ward and K. M. Zangwill, “Haemophilus influenzae vaccines,” in Vaccines, WB Saunders, Philadelphia, Pa, USA, 1999. View at Google Scholar
  257. P. J. Baker, “T cell regulation of the antibody response to bacterial polysaccharide antigens: an examination of some general characteristics and their implications,” Journal of Infectious Diseases, vol. 165, supplement, pp. S44–S48, 1992. View at Publisher · View at Google Scholar · View at Scopus
  258. M. A. Breukels, A. Zandvoort, G. P. J. M. van den Dobbelsteen et al., “Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides,” Infection and Immunity, vol. 69, no. 12, pp. 7583–7587, 2001. View at Publisher · View at Google Scholar · View at Scopus
  259. C. A. Siegrist, “Vaccine immunology,” http://www.who.int/immunization/documents/Elsevier_Vaccine_immunology.pdf.
  260. European Medicines Agency, “Nimenrix,” http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002226/WC500127664.pdf.
  261. Centers for Disease Control and Prevention, “Prevention and control of meningococcal disease: recommendations of the advisory committee on immunization practices (ACIP),” Morbidity and Mortality Weekly Report, vol. 62, no. 2, 2013, http://www.cdc.gov/mmwr/pdf/rr/rr6202.pdf. View at Google Scholar
  262. European Medicines Agency, “Menveo,” http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001095/WC500090150.pdf.
  263. D. Serruto, T. Spadafina, L. Ciucchi et al., “Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 8, pp. 3770–3775, 2010. View at Publisher · View at Google Scholar · View at Scopus
  264. J. A. Welsch, G. R. Moe, R. Rossi, J. Adu-Bobie, R. Rappuoli, and D. M. Granoff, “Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity,” The Journal of Infectious Diseases, vol. 188, no. 11, pp. 1730–1740, 2003. View at Publisher · View at Google Scholar · View at Scopus
  265. J. S. Plested and D. M. Granoff, “Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B,” Clinical and Vaccine Immunology, vol. 15, no. 5, pp. 799–804, 2008. View at Publisher · View at Google Scholar · View at Scopus
  266. G. Madico, J. A. Welsch, L. A. Lewis et al., “The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance,” The Journal of Immunology, vol. 177, no. 1, pp. 501–510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  267. M. C. Schneider, R. M. Exley, H. Chan et al., “Functional significance of factor H binding to Neisseria meningitidis,” The Journal of Immunology, vol. 176, no. 12, pp. 7566–7575, 2006. View at Publisher · View at Google Scholar · View at Scopus
  268. T. Vesikari, S. Esposito, R. Prymula et al., “Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials,” The Lancet, vol. 381, no. 9869, pp. 825–835, 2013. View at Google Scholar
  269. D. Toneatto, P. Oster, A. C. W. DeBoer et al., “Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults,” Human Vaccines, vol. 7, no. 7, pp. 781–791, 2011. View at Publisher · View at Google Scholar · View at Scopus
  270. European Medicines Agency, Bexsero, European Medicines Agency, London, UK, 2013, http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002333/human_med_001614.jsp&mid=WC0b01ac058001d124.
  271. Agenzia Italiana del Farmaco, Determina 29 luglio 2013. Classificazione del medicinale per uso umano “Bexsero”, ai sensi dell'art 8, comma 10, della legge 24 dicembre 1993, n. 537 (Determina 698/2013). Gazzetta Ufficiale—Serie Generale—no. 194 del 20 agosto 2013.
  272. Food and Drug Administration, “Trumenba,” http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM421139.pdf.
  273. L. D. Fletcher, L. Bernfield, V. Barniak et al., “Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein,” Infection and Immunity, vol. 72, no. 4, pp. 2088–2100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  274. D. Zhu, Y. Zhang, V. Barniak, L. Bernfield, A. Howell, and G. Zlotnick, “Evaluation of recombinant lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model,” Infection and Immunity, vol. 73, no. 10, pp. 6838–6845, 2005. View at Publisher · View at Google Scholar · View at Scopus
  275. D. Zhu, V. Barniak, Y. Zhang, B. Green, and G. Zlotnick, “Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis,” Vaccine, vol. 24, no. 26, pp. 5420–5425, 2006. View at Publisher · View at Google Scholar · View at Scopus
  276. A. S. Anderson, L. Hao, Q. Jiang et al., “Potential impact of the bivalent rLP2806vaccine on Neisseria meningitidis carriage and invasive serogroup B disease,” Human Vaccines and Immunotherapeutics, vol. 9, no. 3, pp. 471–479, 2013. View at Publisher · View at Google Scholar · View at Scopus
  277. F. Martinon-Torres, F. Gimenez-Sanchez, E. Bernaola-Iturbe, J. Diez-Domingo, Q. Jiang, and J. L. Perez, “A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants,” Vaccine, vol. 32, no. 40, pp. 5206–5211, 2014. View at Publisher · View at Google Scholar
  278. H. S. Marshall, P. C. Richmond, M. D. Nissen et al., “A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults,” Vaccine, vol. 31, no. 12, pp. 1569–1575, 2013. View at Publisher · View at Google Scholar · View at Scopus
  279. S. L. Harris, D. Zhu, E. Murphy et al., “Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis serogroup C disease,” Human Vaccines, vol. 7, supplement 1, pp. 68–74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  280. M. Konar, D. M. Granoff, and P. T. Beernink, “Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines,” The Journal of Infectious Diseases, vol. 208, no. 4, pp. 627–636, 2013. View at Publisher · View at Google Scholar · View at Scopus
  281. L. Lemée, E. Hong, M. Etienne et al., “Genetic diversity and levels of expression of factor H binding protein among carriage isolates of Neisseria meningitidis,” PLoS ONE, vol. 9, no. 9, Article ID e107240, 2014. View at Publisher · View at Google Scholar
  282. M. Delgado, D. Yero, O. Niebla et al., “Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate,” Vaccine, vol. 25, no. 50, pp. 8420–8431, 2007. View at Publisher · View at Google Scholar · View at Scopus
  283. C.-A. Hsu, W.-R. Lin, J.-C. Li et al., “Immunoproteomic identification of the hypothetical protein NMB1468 as a novel lipoprotein ubiquitous in Neisseria meningitidis with vaccine potential,” Proteomics, vol. 8, no. 10, pp. 2115–2125, 2008. View at Publisher · View at Google Scholar · View at Scopus
  284. A. Pettersson, J. Kortekaas, V. E. Weynants et al., “Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB,” Vaccine, vol. 24, no. 17, pp. 3545–3557, 2006. View at Publisher · View at Google Scholar · View at Scopus
  285. M.-C. Hung, J. E. Heckels, and M. Christodoulides, “The adhesin complex protein (ACP) of Neisseria meningitidis is a new adhesin with vaccine potential,” mBio, vol. 4, no. 2, 2013. View at Google Scholar · View at Scopus
  286. D. Martin, B. R. Brodeur, J. Hamel et al., “Candidate Neisseria meningitidis NspA vaccine,” Journal of Biotechnology, vol. 83, no. 1-2, pp. 27–31, 2000. View at Publisher · View at Google Scholar · View at Scopus
  287. S. Ying, J. He, M. Yu et al., “Recombinant Neisseria surface protein A is a potential vaccine candidate against Neisseria meningitides serogroup B,” Molecular Medicine Reports, vol. 10, no. 3, pp. 1619–1625, 2014. View at Publisher · View at Google Scholar
  288. F. Haghi, S. N. Peerayeh, S. D. Siadat, and H. Zeighami, “Recombinant outer membrane secretin PilQ406–770 as a vaccine candidate for serogroup B Neisseria meningitidis,” Vaccine, vol. 30, no. 9, pp. 1710–1714, 2012. View at Publisher · View at Google Scholar · View at Scopus
  289. S. K. Gupta, S. Smita, A. N. Sarangi, M. Srivastava, B. A. Akhoon, and Q. Rahman, “In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B—A clue for vaccine development,” Vaccine, vol. 28, no. 43, pp. 7092–7097, 2010. View at Publisher · View at Google Scholar · View at Scopus
  290. T. Fiebig, F. Berti, F. Freiberger et al., “Functional expression of the capsule polymerase of Neisseria meningitidis serogroup X: a new perspective for vaccine development,” Glycobiology, vol. 24, no. 2, pp. 150–158, 2014. View at Publisher · View at Google Scholar · View at Scopus
  291. J. Holst, P. Oster, R. Arnold et al., “Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV) lessons from past programs and implications for the future,” Human Vaccines and Immunotherapeutics, vol. 9, no. 6, pp. 1241–1253, 2013. View at Publisher · View at Google Scholar · View at Scopus
  292. J. Newcombe, T. A. Mendum, C.-P. Ren, and J. McFadden, “Identification of the immunoproteome of the meningococcus by cell surface immunoprecipitation and MS,” Microbiology, vol. 160, no. 2, pp. 429–438, 2014. View at Publisher · View at Google Scholar · View at Scopus
  293. E. Altindis, R. Cozzi, B. Di Palo et al., “Protectome analysis: a new selective bioinformatics tool for bacterial vaccine candidate discovery,” Molecular & Cellular Proteomics, vol. 14, no. 2, pp. 418–429, 2015. View at Publisher · View at Google Scholar
  294. M. Christodoulides, “Neisseria proteomics for antigen discovery and vaccine development,” Expert Review of Proteomics, vol. 11, no. 5, pp. 573–591, 2014. View at Publisher · View at Google Scholar
  295. N. E. Rosenstein, B. A. Perkins, D. S. Stephens et al., “The changing epidemiology of meningococcal disease in the United States, 1992–1996,” The Journal of Infectious Diseases, vol. 180, no. 6, pp. 1894–1901, 1999. View at Publisher · View at Google Scholar · View at Scopus
  296. E. Miller, D. Salisbury, and M. Ramsay, “Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story,” Vaccine, vol. 20, supplement 1, pp. S58–S67, 2001. View at Publisher · View at Google Scholar · View at Scopus
  297. R. Gasparini and D. Panatto, “Meningococcal glycoconjugate vaccines,” Human Vaccines, vol. 7, no. 2, pp. 170–182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  298. F. M. La Force, K. Konde, S. Viviani, and M.-P. Préziosi, “The meningitis vaccine project,” Vaccine, vol. 25, supplement 1, pp. 97–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  299. F. Micoli, M. R. Romano, M. Tontini et al., “Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 47, pp. 19077–19082, 2013. View at Publisher · View at Google Scholar · View at Scopus
  300. R. Rappuoli, “The challenge of developing universal vaccines,” F1000 Medicine Reports, vol. 3, article 16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  301. C. L. Trotter, N. J. Gay, and W. J. Edmunds, “Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination,” American Journal of Epidemiology, vol. 162, no. 1, pp. 89–100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  302. H. Campbell, R. Borrow, D. Salisbury, and E. Miller, “Meningococcal C conjugate vaccine: the experience in England and Wales,” Vaccine, vol. 27, supplement 2, pp. B20–B29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  303. R. Gasparini, M. Comanducci, D. Amicizia et al., “Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years,” Journal of Clinical Microbiology, vol. 52, no. 6, pp. 1901–1910, 2014. View at Publisher · View at Google Scholar · View at Scopus
  304. Public Health Agency of Canada, Neisseria SPP, Public Health Agency of Canada, Ottawa, Canada, 2011, http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/neisseria-eng.php.